CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
Presented by CURE®, a collection of resources that provide information and support for patients with squamous cell carcinoma and the professionals who treat them.
July 29th 2021
“There is every reason sunscreen can be promoted on what it does in its ability to reduce your risk of skin cancers over its cosmetic application to prevent the signs of aging,” writes a melanoma survivor.
July 23rd 2021
CURE® offers tips to stay relaxed and healthy during the summer months.
July 21st 2021
An expert from The Skin Cancer Foundation explained how to read sunscreen labels, sun safety practices, common misconceptions about skin cancer and what cancer survivors should know about their risk.
July 17th 2021
In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.
July 15th 2021
Several sunscreens packaged with aerosol were found to contain benzene, which has been associated with risk of leukemia.
July 13th 2021
One expert talks the benefits of excising in surgical management, as well as what to expect after.
July 10th 2021
Skin cancer can have detrimental effects on not only a patient’s physical health, but their emotional and mental health as well, according to an expert at the CURE® Educated Patient® Skin Cancer Summit.
July 9th 2021
On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.
July 8th 2021
Patients with skin cancer who are treated with radiation therapy as an alternative to surgery tend to experience effective results thanks to advanced technologies, according to an expert at the CURE® Educated Patient® Skin Cancer Summit.
July 7th 2021
Patients with melanoma are living longer than ever before and some, according to an expert from the Rutgers Cancer Institute of New Jersey, are even getting cured or achieving long-term remissions thanks to developments in the treatment landscape.
July 6th 2021
Topical treatments may lead to little to no scarring in patients with surface-level skin cancer, but patient characteristics, time of year, tumor characteristics and cost determine course of action.
Anna C. Pavlick, D.O., describes the various challenges health care providers may face when treating patients with locally advanced basal cell carcinoma (laBCC).
Insights into cemiplimab treatment monitoring and management in locally advanced basal cell carcinoma (laBCC).
An expert discusses treatment options available for patients with locally advanced basal cell carcinoma (laBCC) who don’t respond or are intolerant to the first-line therapy option.
The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that cannot be cured by surgery or radiation.
July 5th 2021
As rates of merkel cell carcinoma increase, patients should be aware of the risk factors and symptoms of this skin cancer.
July 1st 2021
After a previous diagnosis of skin cancer, patients are more likely to develop skin cancer lesions on the body. An expert gives helpful tips on what to look for and how to look for lesions to catch them early.
June 30th 2021
Patients with basal cell or cutaneous squamous cell carcinoma tend to have good outcomes when the disease is caught early. For those in later stages, new treatments bring hope and better prognoses.
June 29th 2021
Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).
A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.
An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).
Anna C. Pavlick, D.O., provides an overview of locally advanced basal cell carcinoma (laBCC) that includes the different risk factors and clinical presentations.
June 27th 2021
Learn the differences between sunscreen types and what to look for.
June 26th 2021
View the full CURE Educated Patient Skin Cancer Summit on demand.
June 17th 2021
Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.
June 14th 2021
As we all head outdoors to enjoy the warmer weather, The Skin Cancer Foundation would like to remind everyone how to use sunscreen safely and effectively as part of a complete sun protection strategy.
June 8th 2021
More than six years of follow-up data show that Opdivo alone, or in combination with Yervoy, continued to induce long-term survival benefits compared to Yervoy alone in patients with previously untreated advanced skin cancer.
June 5th 2021
Lifileucel with Keytruda may lead to an improved overall response rate of 86% for patients with advanced melanoma who were pre-checkpoint inhibitor naïve compared with those treated with Keytruda alone.
June 4th 2021
From a cancer survivor who cleans up trash and turns it into artwork to the inaugural National Black Family Cancer Awareness week, here’s what’s happening in the cancer landscape this week.
May 26th 2021
“Summer finds many of us outdoors and during that time, it’s important to protect our skin from the dangerous rays of the sun,” writes one breast cancer survivor. Learn more about how to use sunscreen, protect your skin and avoid skin cancer.
Cancer Care Improvements Have Come ‘Leaps and Bounds’ Over the Years
Oncologists Have Feelings Too: Navigating the Patient Physician Relationship
Debunking Myths of Clinical Trials for Cancer
Highlighting Geographic, Economic Disparities in Cancer Care